Skip to main content
MO logo

Altria Group, Inc. (MO) Stock: Price, Forecast & Analyst Target

Altria Group, Inc. (MO) — MoonshotScore 94/100 (Exceptional band), calculated Nov 18, 2026. Price $74.68 (-2.07%), as of the Nov 19, 2026 trading session; market cap $124B. Expected results Feb 4, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$74.68 −$1.58 (-2.07%) Market Cap $124B

Altria Group, Inc. · MO · NYSE · Consumer Defensive · Tobacco

Research dated 2026-09-12: Altria sells cigarettes, cigars, oral tobacco and nicotine pouches in the United States, chiefly through wholesalers and large retail chains. Marlboro-led smokeable products still dominate the revenue mix, making the durability of those economics—and the ability of smokeless products to become more consequential—the defining tension.

Price as of Nov 19, 2026

Key Statistics

94 of 100

MoonshotScore v2 · Altria Group (MO)

Exceptional
Business Quality Elite (99)
Financial Safety Sound (76)
Valuation Full (53)
Growth Durability Flat (57)
Momentum Surging (83)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite quality and a strong balance sheet, but a full valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Sound; Valuation: Full; Growth Durability: Flat; Momentum: Surging.

  • EPS beat 0 of the last 4 reports
  • expected results Feb 4, 2027
  • Altman Z 5.27 · Piotroski F 7

Helping: business quality, balance-sheet strength, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for MO (57 recorded, newest six shown)
RecordedScoreBand
91Exceptional
91Exceptional
91Exceptional
91Exceptional
94Exceptional
94Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$74.68
Change on the day-2.07%
52-week range$54.70–$79.97
Market capitalisation$124B—
Price / earnings (trailing)15.97
Shares traded on the day8.44M
Beta (volatility vs the S&P 500)0.46

Why Altria Group scores 94

Dr. Mira Sol, the Stock Expert AI TV data character
Business Quality carries the score; Valuation is what holds it back.
Dr. Mira Sol · Data scientist, Stock Expert AI TV (fictional AI character)
94Exceptional
  • Business Quality99
  • Financial Safety76
  • Valuation53
  • Growth Durability57
  • Momentum83

Share price, last 12 months +32.6%

$57.55 $76.34

What the price assumes

2.3% a year of free-cash-flow growth for ten years is what a $126.99B market value ( snapshot) asks for.

  • Price implies, next ten years2.3%
  • Free cash flow, last 5 years2.2%
  • Revenue, last 5 years-0.7%
  • Analysts' revenue path, 2026–20302.2%

The price already assumes faster growth than the last 5 years delivered. Anything short of an acceleration leaves room to disappoint. It also runs ahead of the analysts' revenue path.

Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $9.07B. Inputs: FMP statements, estimates and quote.

How the stock reacts to earnings

EPS beat in 4 of the last 12 reports (2024–2026); the stock still fell the next session after 0 of those beats. Average first-session move: 4.5% either way.

  1. +3.1%Feb ’24
  2. +1.1%Apr ’24
  3. -1.0%Jul ’24
  4. +6.7%Oct ’24
  5. -0.8%Jan ’25
  6. +1.6%Apr ’25
  7. +4.3%Jul ’25
  8. -9.0%Oct ’25
  9. -1.8%Jan ’26
  10. +9.3%Apr ’26
  11. -8.8%Jul ’26
  12. +6.9%Oct ’26
Next-session move EPS beat (4) EPS in line (5) EPS miss (3)
Every report, with revenue and five-session moves
Moves run from the close before the report to the first and fifth closes after it.
ReportEPSRevenueNext session5 sessions
In lineBeat+6.9%+6.3%
MissIn line-8.8%-9.6%
BeatBeat+9.3%+1.2%
MissIn line-1.8%+3.6%
In lineIn line-9.0%-7.6%
BeatBeat+4.3%+6.4%
BeatMiss+1.6%+3.9%
In lineBeat-0.8%-0.0%
BeatIn line+6.7%+6.0%
MissMiss-1.0%-1.0%
In lineIn line+1.1%+2.5%
In lineBeat+3.1%-0.1%

Misses cost real money here: the average first-session move after a miss was -3.9%.

What management is saying differently

Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.

  • New this call: “reduction opportunity”, “highly competitive”, “long-term harm”, “strong financial” — none of them came up in Q2 FY2026.
  • Getting louder: “harm reduction” (3 → 7 mentions), “cigarette category” (2 → 4 mentions).
  • Gone quiet: “disposable e-vapor”, “national expansion”, “pouch consumers”, “product portfolio” — regular themes last call, absent this time.

The tone held steady from one call to the next; what changed is the subject matter, not the confidence.

Our track record on this stock

Since the score went from 87 to 94 while the share price moved +9.1% through .

MoonshotScore (0–100, band floors 45 · 65 · 80) Share price, scaled to its own range

The score has stayed in the Exceptional band across the stretch we have recorded; we grade each band change three months after it happens.

The crowd against our signals

  • Analysts: 62% of 26 rate it a buy; the average target sits -1.2% from the price of $74.68.
  • Last 90 days: 4 rating actions, every one a reaffirmation.
  • Our signals: Exceptional band; strongest pillar Business Quality (99), weakest Valuation (53).

Here we and the crowd agree. Where we differ is on price: our Valuation reading is more cautious than the analysts' targets.

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $56, high $79, latest $75. 4 reported quarters marked, 2 above and 2 below the recorded estimate. $79 $56 high $79 Jan 29, 2026 · Earnings results · reported below the recorded estimate · close $621Apr 30, 2026 · Earnings results · reported above the recorded estimate · close $752Jul 30, 2026 · Earnings results · reported below the recorded estimate · close $683Oct 29, 2026 · Earnings results · reported above the recorded estimate · close $784 Oct 17, 2025 Nov 19, 2026 · $75 $65Oct 17, 2025$56Oct 31, 2025$58Nov 14, 2025$59Nov 28, 2025$59Dec 12, 2025$58Dec 26, 2025$58Jan 9, 2026$62Jan 23, 2026$65Feb 6, 2026$68Feb 20, 2026$67Mar 6, 2026$64Mar 20, 2026$66Apr 2, 2026$64Apr 17, 2026$75May 1, 2026$73May 15, 2026$70May 29, 2026$72Jun 12, 2026$74Jun 26, 2026$72Jul 10, 2026$73Jul 24, 2026$68Aug 7, 2026$66Aug 21, 2026$69Sep 4, 2026$70Sep 18, 2026$67Oct 2, 2026$75Oct 16, 2026$78Oct 30, 2026$79Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · below the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · below the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for Altria Group (MO): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Moderate
Valuation Neutral
Growth Durability Neutral
Momentum Strong

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Strong
Revenue Growth Negative
Gross Margin Strong

Read on: Nov 19, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Altria Group (MO), and what does it report?

Short answer · as of

Altria is a branded nicotine manufacturer and marketer rather than a retailer or a broadly diversified consumer-goods company.

Marlboro anchors cigarettes, Black & Mild covers cigars and pipe tobacco, Copenhagen and Skoal lead moist smokeless tobacco, and on! extends the portfolio into oral nicotine pouches.

The reported segment view divides the business mainly between smokeable and smokeless products. Smokeables contribute overwhelmingly more revenue, so consolidated results still measure the performance of the combustible franchise far more than the progress of oral nicotine.

2 · Latest results

What do the latest results show for Altria Group (MO)?

The latest income-statement period showed higher revenue, gross profit, operating profit and net income than the preceding period and the comparable prior annual period. The earnings comparison was less uniform: revenue exceeded consensus, while earnings per share came in slightly below expectations.

That improvement follows an annual pattern of gradually declining revenue and volatile net income. Because smokeables dominate segment revenue, group-level improvement is not yet evidence that the smaller smokeless portfolio has changed Altria’s economic center of gravity; it is best read as a stronger reported outcome rather than proof of a particular pricing, volume or mix driver.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$5.44B Oct 29, 2026
Latest report · revenue estimate
$5.31B Oct 29, 2026
Latest report · revenue vs estimate
Above estimate Oct 29, 2026
Latest report · EPS vs estimate
Above estimate Oct 29, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Oct 29, 2026$5.44B$5.31B$1.5200$1.5100
Jul 30, 2026$5.36B$5.35B$1.4800$1.5000
Apr 30, 2026$5.36B$4.58B$1.3200$1.2400
Jan 29, 2026$5.08B$5.03B$1.3000$1.3200
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$5.25B$2.38B$1.41 (diluted)
Q4 FY2025$5.08B$1.12B—
Q1 FY2026$4.76B$2.18B$1.30 (diluted)
Q2 FY2026$5.36B$2.30B$1.37 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Altria Group (MO)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Altria combines unusually high reported margins with modest capital expenditure, and its quality and distress screens are favorable. Operating cash flow has been substantial in many reporting periods, but the latest period turned negative despite strong accounting profit, showing that cash realization can be uneven.

Near-term cash and investments sit well below total debt. Including the larger pool of unclassified long-term investments narrows that gap, but those holdings should not be treated as equivalent to immediately available liquidity; negative equity also makes conventional leverage and return-on-equity ratios difficult to interpret.

The damaging combination would be weaker smokeable-product economics alongside persistently poor cash conversion. Smokeable concentration would transmit that pressure across the group, while the debt load would leave less room for cash-flow volatility.

4 · What to check next?

What should you watch next at Altria Group (MO)?

Short answer · as of

The next earnings report is expected on Feb 4, 2027.

Revenue quality deserves attention at the scheduled earnings release: watch for continued improvement in gross and operating profit, an earnings result that no longer trails consensus, and a rebound in operating cash flow. Agreement among those measures would be more informative than another isolated swing in net income.

Cash and short-term investments have declined from their recent peak across successive reporting periods, so stabilization there would strengthen the cash-conversion picture. The longer-range consensus path assumes gradual revenue and earnings growth; sustained top-line progress would support that path more directly than profit volatility.

Product mix remains the strategic checkpoint. Movement in smokeless revenue must become meaningful relative to the Marlboro-led smokeable base before the company’s dependence on combustible products materially changes.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Altria Group compare with its peers?

Short answer

Altria Group's score ranks 1st of 11 in the bounded comparison shown, against 10 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Altria’s distinctive profile is a domestic portfolio spanning Marlboro cigarettes, Black & Mild cigars, established moist-smokeless brands and on! nicotine pouches, all routed largely through wholesale partners and major retail chains. Its breadth stays inside tobacco and nicotine rather than extending across unrelated consumer categories.

The financial resemblance to a mature tobacco business is clear in high margins, limited capital spending and strong cash generation during many periods. What separates the current mix from a balanced smoke-free model is the continuing revenue dominance of smokeable products, while leverage and uneven cash conversion remain important counterweights to those economics.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Altria Group (MO) — this page$74.68$124B94
Colgate-Palmolive Company (CL) Named competitor$98.85 Nov 18, 2026$78.6B93 5-pillar Nov 18, 2026
Philip Morris International Inc. (PM) Same industry, near in market value$186.43 Nov 19, 2026$291B92 5-pillar Nov 18, 2026
British American Tobacco p.l.c. (BTI) Named competitor$57.46 Nov 19, 2026$123B87 5-pillar Nov 18, 2026
Anheuser-Busch InBev SA/NV (BUD) Named competitor$82.98 Nov 18, 2026$163B78 5-pillar Nov 18, 2026
Mondelez International, Inc. (MDLZ) Named competitor$65.69 Nov 19, 2026$83.2B72 5-pillar Nov 18, 2026
Diageo plc (DEO) Named competitor$98.33 Nov 19, 2026$54.8B72 5-pillar Nov 18, 2026
RLX Technology Inc. (RLX) Same industry, near in market value$1.46 Nov 19, 2026$1.78B67 5-pillar Nov 18, 2026
Turning Point Brands, Inc. (TPB) Same industry, near in market value$47.53 Nov 18, 2026$945M57 5-pillar Nov 18, 2026
Universal Corporation (UVV) Same industry, near in market value$32.97 Nov 19, 2026$822M47 5-pillar Nov 18, 2026
Greenlane Holdings, Inc. (GNLN) Same industry, near in market value$0.76 Nov 19, 2026—16 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Consumer Defensive stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$58.00 – $85.00
Consensus target
$73.80
Median target
$83.00

Consensus record · Captured .

Measured against a quoted price of $74.68 (as of Nov 19, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 14, 2026

Transactions
4
Identified insiders
4
Purchases
1
Sales
2
Other transactions
1

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held MO in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.62%$141.46MAdded +21.6% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Common Questions About MO (Consumer Defensive)

The last 2 questions are answered from this page's own dated data, not from the research.

Why does Marlboro matter more than on! to Altria today?

Marlboro sits within the smokeable franchise, which overwhelmingly dominates reported segment revenue, while on! belongs to the much smaller smokeless portfolio. Near-term group economics are therefore more sensitive to smokeables than to the present scale of oral nicotine pouches.

How do Altria’s wholesale partners and major chain stores reach nicotine consumers?

Altria primarily sells through independent distributors and directly to large retail organizations. Consumer demand reaches Altria through product movement across those channels rather than through a company-operated store network.

What do Copenhagen, Skoal and on! add to Altria’s portfolio?

Copenhagen and Skoal provide established moist-smokeless offerings, while on! adds oral nicotine pouches. These products broaden the available formats, but their segment remains far smaller than smokeable products.

Why are Black & Mild and Marlboro part of Altria’s smokeable business?

Marlboro is the principal cigarette brand, whereas Black & Mild is concentrated in cigars and pipe tobacco. The formats differ, but each belongs to Altria’s combustible product portfolio and reinforces the company’s exposure to smokeable categories.

What is the MO stock price today?

The last price recorded for Altria Group, Inc. (MO), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the MO price target?

The analyst consensus price target for Altria Group, Inc. (MO), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 41 figures on this page — 1 from SEC filings and earnings calls, 34 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Sector / industry (provider taxonomy); Revenue by segment; Annual revenue and net result (USD millions)
  • 1. What is Altria Group (MO), and what does it report?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Annual revenue and net result (USD millions)
  • 2. What do the latest results show for Altria Group (MO)?: Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Revenue by segment; Reported versus estimated, last 8 quarters; Most recent periodic reports
  • 3. What are the financial strengths and risks for Altria Group (MO)?: Trailing twelve-month ratio set; Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash against market value; Distress and quality screens; Revenue by segment; Quarterly income statement (USD thousands)
  • 4. What should you watch next at Altria Group (MO)?: Next earnings report; Analyst revenue and earnings estimates (average); Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Revenue by segment; Recent SEC filings
  • 5. How does Altria Group compare with its peers?: Business description; Sector / industry (provider taxonomy); Revenue by segment; Trailing twelve-month ratio set; Operating cash flow by quarter (USD millions); Cash, investments and debt; Distress and quality screens
  • FAQ: Why does Marlboro matter more than on! to Altria today?: Business description; Revenue by segment
  • FAQ: How do Altria’s wholesale partners and major chain stores reach nicotine consumers?: Business description
  • FAQ: What do Copenhagen, Skoal and on! add to Altria’s portfolio?: Business description; Revenue by segment
  • FAQ: Why are Black & Mild and Marlboro part of Altria’s smokeable business?: Business description; Revenue by segment
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold MO

Funds in our ETF coverage that list MO among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
WisdomTree U.S. High Dividend Fund (DHS)5.01%
AdvisorShares Vice ETF (VICE)4.79%
Leatherback Long/Short Alternative Yield ETF (LBAY)4.52%
Genter Capital Dividend Income ETF (GEND)3.98%
VictoryShares Dividend Accelerator ETF (VSDA)3.84%
iShares Evolved U.S. Consumer Staples ETF (IECS)3.66%
FSTA ETF3.53%
UVA Dividend Value ETF (UVDV)2.47%
Pacer US Cash Cows 100 ETF (COWZ)2.20%
Global X - Adaptive U.S. Factor ETF (AUSF)1.61%